Join us July 9th and 10th for the KAND Family & Scientific Engagement Conference hosted by KIF1A.ORG. Register here to join the conversation and learn about the latest research and ...
BioLoomics is joining KIF1A.ORG in its search for a treatment and cure for KIF1A-Associated Neurological Disorder (KAND). We are applying our evolution-in-a-microscope technology to build high throughput drug discovery ...
BioLoomics closed a $575,000 round of seed funding on May 11, 2021. The funds were contributed by private investors, including several investors who participated in the pre-seed round. BioLoomics will ...
